All news

Macquarie keeps Buy on RMD with A$46.60 target

Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash

Macquarie has maintained a Buy rating on Resmed Inc CHESS Depositary Interests (RMD) with a price target of A$46.60. This positive outlook is supported by recent earnings, which showed a quarterly revenue of A

Read original source

RMD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.